Expert-Led Assessment Services for Strategic Acquisitions and Partnerships
To know more about the rules,
Please Fill the Form
To learn more, connect with us
As the Indian medical device industry matures, cross-border acquisitions and strategic alliances with European entities are becoming essential pathways for growth. However, behind every successful deal lies a complex web of regulatory risks, especially in the highly structured and safety-driven EU medical device regulatory environment governed by MDR (Regulation EU 2017/745).
At CliniExperts, we specialize in conducting in-depth EU regulatory due diligence tailored specifically for Indian manufacturers. Our services are built to provide a full-spectrum compliance risk assessment—covering product approvals, technical documentation, QMS, post-market surveillance, and facility readiness.
Confirming CE certification validity and regulatory lifecycle status.
Identifying potential non-conformities that may lead to product withdrawal or Notified Body rejection.
Verifying QMS compliance with ISO 13485:2016 and MDR Article 10 obligations.
Exposing gaps in PMS/PSUR, CAPA handling, and vigilance systems that may impact valuation.
Entering the EU market or acquiring a European manufacturer demands far more than financial feasibility and product portfolio alignment. Regulatory due diligence is the gatekeeper to assessing the true operational and commercial value of the target.
Comprehensive evaluation of certificates, scope, and conformity routes
Assessment of technical files, clinical evaluations, and risk management
Analysis of labeling, IFUs, and claims substantiation
Verification of ISO 13485:2016 compliance and MDR readiness
Review of vigilance systems and field safety procedures
Assessment of regulatory correspondence and certification status
Evaluate CE certificates, scope, expiration, and conformity routes (MDR vs MDD/AIMDD legacy).
Assess alignment of the product classification and GMDN coding.
Review any conditions imposed by the Notified Body.
Evaluate technical documentation per Annex II & III of EU MDR.
Assess GSPR coverage, clinical evaluation reports (CERs), and risk management files.
Audit design dossiers and PMCF documentation.
Assess language requirements, UDI implementation, and claims substantiation.
Check traceability elements and alignment with UDI-DI (if applicable).
Analyze labeling and IFUs for compliance with Annex I, Chapter III of EU MDR.
Audit facility compliance with international standards.
Assess internal practices and management review efficacy.
Evaluate readiness for unannounced audits.
Audit facility compliance with ISO 13485:2016 and MDR Article 10. Assess internal audit practices, management review efficacy, and document controls. Evaluate readiness for unannounced audits and Notified Body inspections.
Review PSURs, PMS reports, vigilance history, and trend analysis records.
Evaluate Field Safety Corrective Actions (FSCA) and incident investigation quality.
Assess integration with EUDAMED vigilance modules.
CliniExperts is your strategic partner for technical and regulatory due diligence in EU device transactions. We empower Indian manufacturers with precision insight to navigate the European regulatory landscape confidently.